BridgeMD
Comparison of PENG block and lumbar plexus block in terms of postoperative analgesia and mobilization for fast track primary hip arthroplasty
EU CTIS ID: 2023-507506-14-01
What this study is testing
To compare two regional anaesthesia techniques for primary hip replacement in terms of pain relief and muscular strength of the quadriceps
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients scheduled for primary hip replacement who agree to participate in the study and sign the informed consent
You likely can't join if
- Refusal to participate in the study
- blood coagulation dysfunction
- Neuropathies
- Punction site or systemic infections
- Local anesthestic alergies
- Women of reproductive age without contraceptive control, maternity or breastfeeding
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.